Dr. Gerhard Stvarnik is responsible for Quality Management and he is the Qualified Person as per EU Directive 2001/83/EC and 2001/20/EC respectively. In his role Gerhard assures together with his team the regulatory compliance of Hookipa, the physical control of investigational medicinal products and the adherence to GMP process Quality of the organization. Prior to joining Hookipa he was with Baxter for 25 years leading with increasing responsibility Manufacturing, Regulatory and Quality. After leaving Baxter he was CEO of the Austrian cancer therapy start-ups Cellmed and Cellpro Danube. He also has a 10 years’ experience as Quality Assurance Consultant in the Biological Pharmaceutical Industry. Gerhard holds a PhD in Chemistry and Physics from the University of Graz, Austria.